Fidelity Investments’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-232,815
Closed -$202K 5617
2023
Q2
$202K Sell
232,815
-10,320
-4% -$7.36K ﹤0.01% 2946
2023
Q1
$170K Buy
243,135
+9,942
+4% +$8.06K ﹤0.01% 3041
2022
Q4
$191K Sell
233,193
-140,453
-38% -$138K ﹤0.01% 3020
2022
Q3
$388K Sell
373,646
-1,580
-0.4% -$2.52K ﹤0.01% 2857
2022
Q2
$616K Sell
375,226
-422,195
-53% -$877K ﹤0.01% 2788
2022
Q1
$2.34M Buy
797,421
+93,264
+13% +$327K ﹤0.01% 2560
2021
Q4
$3.37M Sell
704,157
-318,520
-31% -$2.06M ﹤0.01% 2452
2021
Q3
$7.74M Hold
1,022,677
﹤0.01% 2218
2021
Q2
$7.63M Hold
1,022,677
﹤0.01% 2208
2021
Q1
$7.98M Hold
1,022,677
﹤0.01% 2120
2020
Q4
$9.45M Buy
1,022,677
+686,900
+205% +$5.97M ﹤0.01% 1989
2020
Q3
$2.32M Buy
335,777
+197,923
+144% +$1.2M ﹤0.01% 2274
2020
Q2
$904K Sell
137,854
-135,585
-50% -$489K ﹤0.01% 2413
2020
Q1
$511K Buy
273,439
+800
+0.3% +$2.11K ﹤0.01% 2429
2019
Q4
$513K Sell
272,639
-44,796
-14% -$74.6K ﹤0.01% 2493
2019
Q3
$451K Hold
317,435
﹤0.01% 2533
2019
Q2
$895K Sell
317,435
-272,232
-46% -$1.08M ﹤0.01% 2467
2019
Q1
$2.81M Hold
589,667
﹤0.01% 2224
2018
Q4
$2.5M Sell
589,667
-1,676,610
-74% -$12.9M ﹤0.01% 2232
2018
Q3
$24.8M Sell
2,266,277
-674,993
-23% -$7.91M ﹤0.01% 1593
2018
Q2
$48M Buy
+2,941,270
New +$42.6M 0.01% 1293

Fidelity Investments's SURF Position: Q3 2023 in Review

Fidelity Investments sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 232,815 shares — an estimated $202K sold.

Fidelity Investments first reported a position in SURF in Q2 2018 and held it in 21 quarters. The position peaked at $48M in Q2 2018. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

  • Fidelity Investments reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Fidelity Investments sold 232,815 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $202K.
  • Fidelity Investments first reported a position in Surface Oncology, Inc. Common Stock in Q2 2018 and held it in 21 quarters.
  • Fidelity Investments's Surface Oncology, Inc. Common Stock position peaked at $48M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on Fidelity Investments's 13F filing for Q3 2023, filed 13 Nov 2023.